118 related articles for article (PubMed ID: 38585253)
21. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
Molecules; 2018 May; 23(6):. PubMed ID: 29861433
[TBL] [Abstract][Full Text] [Related]
22. Cardioprotective Effect of Resistance Exercise on Left Ventricular Remodeling Associated with Monocrotaline-Induced Pulmonary Arterial Hypertension.
Oliveira-Junior SA; Ogura AY; Carvalho MR; Martinez PF
Arq Bras Cardiol; 2022 Oct; 119(4):585-586. PubMed ID: 36287413
[No Abstract] [Full Text] [Related]
23. Ruscogenin exerts beneficial effects on monocrotaline-induced pulmonary hypertension by inhibiting NF-κB expression.
Zhu R; Bi L; Kong H; Xie W; Hong Y; Wang H
Int J Clin Exp Pathol; 2015; 8(10):12169-76. PubMed ID: 26722401
[TBL] [Abstract][Full Text] [Related]
24. Astragalus Polysaccharides Attenuate Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats.
Yuan LB; Hua CY; Gao S; Yin YL; Dai M; Meng HY; Li PP; Yang ZX; Hu QH
Am J Chin Med; 2017; 45(4):773-789. PubMed ID: 28521513
[TBL] [Abstract][Full Text] [Related]
25. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
26. Forsythoside B alleviates osteoarthritis through the HMGB1/TLR4/NF-κB and Keap1/Nrf2/HO-1 pathways.
Li S; Li Y; Hou L; Tang L; Gao F
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23569. PubMed ID: 37943572
[TBL] [Abstract][Full Text] [Related]
27. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
[TBL] [Abstract][Full Text] [Related]
28. Dihydroartemisinin Attenuates Pulmonary Hypertension Through Inhibition of Pulmonary Vascular Remodeling in Rats.
Tang M; Wang R; Feng P; Dong Q; Chen W; Zhao Y; Li A; Li H; Chen J; Huang W
J Cardiovasc Pharmacol; 2020 Sep; 76(3):337-348. PubMed ID: 32569012
[TBL] [Abstract][Full Text] [Related]
29. Nanoparticle-mediated delivery of nuclear factor kappaB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension.
Kimura S; Egashira K; Chen L; Nakano K; Iwata E; Miyagawa M; Tsujimoto H; Hara K; Morishita R; Sueishi K; Tominaga R; Sunagawa K
Hypertension; 2009 May; 53(5):877-83. PubMed ID: 19307469
[TBL] [Abstract][Full Text] [Related]
30. In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression.
Le Ribeuz H; Courboulin A; Ghigna MR; Lambert M; Hautefort A; Humbert M; Montani D; Cohen-Kaminsky S; Perros F; Antigny F
Respir Res; 2020 Jul; 21(1):186. PubMed ID: 32678044
[TBL] [Abstract][Full Text] [Related]
31. [Effect of chrysin on expression of NOX4 and NF-κB in right ventricle of monocrotaline-induced pulmonary arterial hypertension of rats].
Li XW; Guo B; Shen YY; Yang JR
Yao Xue Xue Bao; 2015 Sep; 50(9):1128-34. PubMed ID: 26757549
[TBL] [Abstract][Full Text] [Related]
32. Chronic Inhibition of Toll-Like Receptor 9 Ameliorates Pulmonary Hypertension in Rats.
Ishikawa T; Abe K; Takana-Ishikawa M; Yoshida K; Watanabe T; Imakiire S; Hosokawa K; Hirano M; Hirano K; Tsutsui H
J Am Heart Assoc; 2021 Apr; 10(7):e019247. PubMed ID: 33787285
[TBL] [Abstract][Full Text] [Related]
33. Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
Tang Y; Tan S; Li M; Tang Y; Xu X; Zhang Q; Fu Q; Tang M; He J; Zhang Y; Zheng Z; Peng J; Zhu T; Xie W
BMC Pulm Med; 2022 Apr; 22(1):142. PubMed ID: 35413880
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of hydrogen sulfide on monocrotaline‑induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition.
Zhang H; Lin Y; Ma Y; Zhang J; Wang C; Zhang H
Int J Mol Med; 2019 Dec; 44(6):2091-2102. PubMed ID: 31573044
[TBL] [Abstract][Full Text] [Related]
35. The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity.
Zimmer A; Teixeira RB; Constantin RL; Campos-Carraro C; Aparicio Cordero EA; Ortiz VD; Donatti L; Gonzalez E; Bahr AC; Visioli F; Baldo G; Luz de Castro A; Araujo AS; Belló-Klein A
Eur J Pharmacol; 2021 Jan; 891():173699. PubMed ID: 33160936
[TBL] [Abstract][Full Text] [Related]
36. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.
Huang WC; Ke MW; Cheng CC; Chiou SH; Wann SR; Shu CW; Chiou KR; Tseng CJ; Pan HW; Mar GY; Liu CP
PLoS One; 2016; 11(2):e0142476. PubMed ID: 26840075
[TBL] [Abstract][Full Text] [Related]
38. Endogenous hydrogen sulfide sulfhydrates IKKβ at cysteine 179 to control pulmonary artery endothelial cell inflammation.
Zhang D; Wang X; Chen S; Chen S; Yu W; Liu X; Yang G; Tao Y; Tang X; Bu D; Zhang H; Kong W; Tang C; Huang Y; Du J; Jin H
Clin Sci (Lond); 2019 Oct; 133(20):2045-2059. PubMed ID: 31654061
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-β1/smad2/3 signaling.
Li P; Song J; Du H; Lu Y; Dong S; Zhou S; Guo Z; Wu H; Zhao X; Qin Y; Zhu N
J Mol Cell Cardiol; 2021 Dec; 161():9-22. PubMed ID: 34339758
[TBL] [Abstract][Full Text] [Related]
40. [Pulmonary Vascular Remodeling Characteristics of Pulmonary Arterial Hypertension Mouse Model Induced by Left Pneumonectomy and Jugular Vein Injection of Monocrotaline Pyrrole].
Gu L; Liu CJ; Xie L; Gu L; Yu L; Liu HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):821-827. PubMed ID: 36224684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
